Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Norwegian (OSEAX) Biotech Industry Analysis

UpdatedJun 24, 2026
DataAggregated Company Financials
Companies8
  • 7D0.3%
  • 3M-4.7%
  • 1Y36.0%
  • YTD0.2%

Over the last 7 days, the Biotech industry has dropped 1.1%, driven by a pullback from Zelluna of 7.3%. This takes the industry's 12 month performance to a gain of 35%. Earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the Norwegian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 24 Jun 2026NOK 5.5bNOK 549.2m-NOK 385,392,957.1440.4x-14.2x9.9x
Fri, 22 May 2026NOK 5.8bNOK 547.9m-NOK 352,523,263.0039.8x-16.4x10.5x
Sun, 19 Apr 2026NOK 6.0bNOK 545.8m-NOK 388,664,514.8051.6x-15.5x11x
Tue, 17 Mar 2026NOK 5.7bNOK 545.2m-NOK 379,423,378.6057.3x-15.1x10.5x
Thu, 12 Feb 2026NOK 6.0bNOK 602.5m-NOK 361,453,382.4478x-16.7x10x
Sat, 10 Jan 2026NOK 5.6bNOK 607.2m-NOK 368,404,886.1288.6x-15.2x9.2x
Mon, 08 Dec 2025NOK 4.8bNOK 607.2m-NOK 368,492,902.1272.3x-13.1x7.9x
Wed, 05 Nov 2025NOK 5.0bNOK 608.0m-NOK 413,717,832.79255.8x-12.1x8.2x
Fri, 03 Oct 2025NOK 4.6bNOK 611.8m-NOK 517,718,722.28244.9x-8.9x7.5x
Sun, 31 Aug 2025NOK 4.6bNOK 614.3m-NOK 494,843,317.07260.4x-9.4x7.6x
Tue, 29 Jul 2025NOK 4.9bNOK 885.9m-NOK 747,317,591.22217.1x-6.5x5.5x
Thu, 26 Jun 2025NOK 4.8bNOK 885.4m-NOK 745,741,865.39189.8x-6.4x5.4x
Sat, 24 May 2025NOK 5.0bNOK 894.0m-NOK 881,010,047.19189.2x-5.7x5.6x
Mon, 21 Apr 2025NOK 4.7bNOK 520.3m-NOK 1,020,717,842.73114.7x-4.6x9.1x
Wed, 19 Mar 2025NOK 4.9bNOK 520.8m-NOK 1,098,045,952.19115.1x-4.5x9.5x
Fri, 14 Feb 2025NOK 5.1bNOK 457.3m-NOK 1,122,407,354.72172.6x-4.5x11.2x
Sun, 12 Jan 2025NOK 4.6bNOK 458.1m-NOK 1,078,107,616.98157.4x-4.3x10.1x
Tue, 10 Dec 2024NOK 4.3bNOK 456.5m-NOK 1,064,255,412.26146.8x-4.1x9.5x
Thu, 07 Nov 2024NOK 4.1bNOK 472.9m-NOK 1,075,132,975.8048.2x-3.9x8.8x
Sat, 05 Oct 2024NOK 5.0bNOK 470.1m-NOK 1,059,165,831.8558.9x-4.7x10.7x
Mon, 02 Sep 2024NOK 6.0bNOK 471.3m-NOK 1,035,118,355.3066.3x-5.8x12.7x
Wed, 31 Jul 2024NOK 9.3bNOK 517.3m-NOK 1,054,492,149.6174.9x-8.8x17.9x
Fri, 28 Jun 2024NOK 9.1bNOK 642.0m-NOK 942,400,959.2137.4x-9.6x14.1x
Sun, 26 May 2024NOK 9.0bNOK 630.4m-NOK 976,448,522.3438.6x-9.2x14.3x
Tue, 23 Apr 2024NOK 8.6bNOK 660.3m-NOK 962,444,295.7437.4x-8.9x13x
Thu, 21 Mar 2024NOK 8.9bNOK 654.7m-NOK 934,223,461.6039.2x-9.6x13.6x
Sat, 17 Feb 2024NOK 15.1bNOK 671.9m-NOK 1,003,515,434.3037.4x-15.1x22.5x
Mon, 15 Jan 2024NOK 16.4bNOK 654.1m-NOK 1,352,223,251.0059.2x-12.1x25x
Wed, 13 Dec 2023NOK 15.2bNOK 664.1m-NOK 1,381,204,144.0058.5x-11x22.9x
Fri, 10 Nov 2023NOK 14.4bNOK 620.2m-NOK 1,471,136,123.0057.4x-9.8x23.2x
Sun, 08 Oct 2023NOK 14.6bNOK 627.1m-NOK 1,464,513,549.0049.6x-10x23.4x
Tue, 05 Sep 2023NOK 15.8bNOK 625.9m-NOK 1,425,212,068.0058.3x-11.1x25.2x
Thu, 03 Aug 2023NOK 15.9bNOK 556.5m-NOK 1,457,696,286.0055.8x-10.9x28.6x
Sat, 01 Jul 2023NOK 15.1bNOK 561.6m-NOK 1,478,500,076.0060.8x-10.2x27x
Price to Earnings Ratio

-10.2x


Total Market Cap: NOK 15.1bTotal Earnings: -NOK 1,478,500,076.00Total Revenue: NOK 561.6mTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Biotech Industry Price to Earnings3Y Average -9.4x202420252026
Current Industry PE
  • Investors are pessimistic on the Norwegian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 13.7x is higher than the industry's current PS ratio of 10.0x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market-0.51%
Healthcare0.95%
Biotech0.31%
Biotech0.31%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CRNA Circio HoldingNOK 8.352.3%
+NOK 45.2m		1,204.7%PE-43.3x
HBC Hofseth BioCareNOK 1.256.4%
+NOK 30.8m		-33.5%PS2x
LYTIX Lytix BiopharmaNOK 9.304.5%
+NOK 30.8m		-4.9%PB11.6x
NYKD Nykode TherapeuticsNOK 3.222.2%
+NOK 22.9m		80.7%PS195.1x
TRMED Thor MedicalNOK 4.200.2%
+NOK 3.6m		63.9%PS1806.9x

Latest News

ZLNA
NOK 19.00
Zelluna
7D
-7.3%
1Y
39.8%
TRMED
NOK 4.20
Thor Medical
7D
0.2%
1Y
63.9%
ABS
NOK 3.30
Arctic Bioscience
7D
-3.8%
1Y
-5.4%
AZT
NOK 20.10
ArcticZymes Technologies
7D
-0.5%
1Y
21.1%
LYTIX
NOK 9.30
Lytix Biopharma
7D
4.5%
1Y
-4.9%
Analysis Article • Jun 02

We're Hopeful That Lytix Biopharma (OB:LYTIX) Will Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
NYKD
NOK 3.22
Nykode Therapeutics
7D
2.2%
1Y
80.7%
New Narrative • May 19

Head And Neck Cancer Trial Progress And Cash Runway Will Support Long Term Potential

Catalysts About Nykode Therapeutics Nykode Therapeutics is a biotechnology company focused on developing immunotherapies for cancer and autoimmune diseases. What are the underlying business or industry changes driving this perspective?
CRNA
NOK 8.35
Circio Holding
7D
2.3%
1Y
1,204.7%
EXTX
NOK 0.77
EXACT Therapeutics
7D
-8.9%
1Y
-70.6%
HBC
NOK 1.25
Hofseth BioCare
7D
6.4%
1Y
-33.5%